Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum

Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8
Hauptverfasser: He, Zhengxiang, Chen, Lili, Chen, Grace, Smaldini, Paola, Bongers, Gerold, Catalan-Dibene, Jovani, Furtado, Glaucia C., Lira, Sergio A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1583.e8
container_issue 6
container_start_page 1572
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 157
creator He, Zhengxiang
Chen, Lili
Chen, Grace
Smaldini, Paola
Bongers, Gerold
Catalan-Dibene, Jovani
Furtado, Glaucia C.
Lira, Sergio A.
description Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps. We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing. Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation. In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immun
doi_str_mv 10.1053/j.gastro.2019.08.025
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2283106221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0016508519412456</els_id><sourcerecordid>2283106221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</originalsourceid><addsrcrecordid>eNp9kcuO1DAQRS0EYpqBP0DISzYJZTvpuDdIqOfBSNMC8VhbflTATRIH2xmYHf_Ait_jS3CrB5asSqU6VfeWLiFPGdQMWvFiX3_SKcdQc2CbGmQNvL1HVqzlsgJg_D5ZlbKuWpDtCXmU0h4ANkKyh-REsKYrXbciv66mjHHA5YufKKMGs6Z6cnSnc_Tf6a70wxBmnLN3OiEVdBumMjJLRpoDPcMbLPMRp0xDT89n7zCOeqCXMXzLn-mFtjlE-g5tORHi7x8_z3DGyR349xijzujo2zDczokWB7uwFJEt2mV8TB70ekj45K6eko8X5x-2r6vrN5dX21fXlW1A5so0PWLbuk6j2BiHwHve4EY3jVyL3moJmjtjrDGi62SPRgCi6LhzsLam5eKUPD_enWP4umDKavTJ4jDoCYsbxbkUDNacs4I2R9TGkFLEXs3RjzreKgbqEIraq2Mo6hCKAqlKKGXt2Z3CYkZ0_5b-plCAl0cAy583HqNK1uNk0fmINisX_P8V_gDJzaRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2283106221</pqid></control><display><type>article</type><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><creator>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</creator><creatorcontrib>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</creatorcontrib><description>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps. We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing. Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation. In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development. [Display omitted]</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2019.08.025</identifier><identifier>PMID: 31470007</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis - immunology ; Barrier Breakdown ; Cecum - cytology ; Cecum - immunology ; Cecum - pathology ; Colonic Polyps - immunology ; Cytokine ; Diphtheria Toxin - administration &amp; dosage ; Diphtheria Toxin - immunology ; Disease Models, Animal ; Epithelial Cells - immunology ; Epithelial Cells - pathology ; ErbB Receptors - antagonists &amp; inhibitors ; ErbB Receptors - metabolism ; Fibroblasts - immunology ; Fibroblasts - metabolism ; Gefitinib - pharmacology ; Heparin-binding EGF-like Growth Factor - genetics ; Heparin-binding EGF-like Growth Factor - metabolism ; Humans ; Hydroxamic Acids - pharmacology ; Interleukin-1beta - immunology ; Interleukin-1beta - metabolism ; Intestinal Mucosa - cytology ; Intestinal Mucosa - immunology ; Intestinal Mucosa - pathology ; Matrix Metalloproteinase 3 - immunology ; Matrix Metalloproteinase 3 - metabolism ; Matrix Metalloproteinase Inhibitors - pharmacology ; Mice ; Mice, Transgenic ; Neoplasm ; Receptor, Platelet-Derived Growth Factor alpha - metabolism ; Stroma ; Sulfonamides - pharmacology</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8</ispartof><rights>2019 AGA Institute</rights><rights>Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</citedby><cites>FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</cites><orcidid>0000-0002-3187-120X ; 0000-0002-2734-516X ; 0000-0003-2170-7462 ; 0000-0002-8961-859X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2019.08.025$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31470007$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Zhengxiang</creatorcontrib><creatorcontrib>Chen, Lili</creatorcontrib><creatorcontrib>Chen, Grace</creatorcontrib><creatorcontrib>Smaldini, Paola</creatorcontrib><creatorcontrib>Bongers, Gerold</creatorcontrib><creatorcontrib>Catalan-Dibene, Jovani</creatorcontrib><creatorcontrib>Furtado, Glaucia C.</creatorcontrib><creatorcontrib>Lira, Sergio A.</creatorcontrib><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps. We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing. Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation. In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development. [Display omitted]</description><subject>Animals</subject><subject>Apoptosis - immunology</subject><subject>Barrier Breakdown</subject><subject>Cecum - cytology</subject><subject>Cecum - immunology</subject><subject>Cecum - pathology</subject><subject>Colonic Polyps - immunology</subject><subject>Cytokine</subject><subject>Diphtheria Toxin - administration &amp; dosage</subject><subject>Diphtheria Toxin - immunology</subject><subject>Disease Models, Animal</subject><subject>Epithelial Cells - immunology</subject><subject>Epithelial Cells - pathology</subject><subject>ErbB Receptors - antagonists &amp; inhibitors</subject><subject>ErbB Receptors - metabolism</subject><subject>Fibroblasts - immunology</subject><subject>Fibroblasts - metabolism</subject><subject>Gefitinib - pharmacology</subject><subject>Heparin-binding EGF-like Growth Factor - genetics</subject><subject>Heparin-binding EGF-like Growth Factor - metabolism</subject><subject>Humans</subject><subject>Hydroxamic Acids - pharmacology</subject><subject>Interleukin-1beta - immunology</subject><subject>Interleukin-1beta - metabolism</subject><subject>Intestinal Mucosa - cytology</subject><subject>Intestinal Mucosa - immunology</subject><subject>Intestinal Mucosa - pathology</subject><subject>Matrix Metalloproteinase 3 - immunology</subject><subject>Matrix Metalloproteinase 3 - metabolism</subject><subject>Matrix Metalloproteinase Inhibitors - pharmacology</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Neoplasm</subject><subject>Receptor, Platelet-Derived Growth Factor alpha - metabolism</subject><subject>Stroma</subject><subject>Sulfonamides - pharmacology</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcuO1DAQRS0EYpqBP0DISzYJZTvpuDdIqOfBSNMC8VhbflTATRIH2xmYHf_Ait_jS3CrB5asSqU6VfeWLiFPGdQMWvFiX3_SKcdQc2CbGmQNvL1HVqzlsgJg_D5ZlbKuWpDtCXmU0h4ANkKyh-REsKYrXbciv66mjHHA5YufKKMGs6Z6cnSnc_Tf6a70wxBmnLN3OiEVdBumMjJLRpoDPcMbLPMRp0xDT89n7zCOeqCXMXzLn-mFtjlE-g5tORHi7x8_z3DGyR349xijzujo2zDczokWB7uwFJEt2mV8TB70ekj45K6eko8X5x-2r6vrN5dX21fXlW1A5so0PWLbuk6j2BiHwHve4EY3jVyL3moJmjtjrDGi62SPRgCi6LhzsLam5eKUPD_enWP4umDKavTJ4jDoCYsbxbkUDNacs4I2R9TGkFLEXs3RjzreKgbqEIraq2Mo6hCKAqlKKGXt2Z3CYkZ0_5b-plCAl0cAy583HqNK1uNk0fmINisX_P8V_gDJzaRQ</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>He, Zhengxiang</creator><creator>Chen, Lili</creator><creator>Chen, Grace</creator><creator>Smaldini, Paola</creator><creator>Bongers, Gerold</creator><creator>Catalan-Dibene, Jovani</creator><creator>Furtado, Glaucia C.</creator><creator>Lira, Sergio A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3187-120X</orcidid><orcidid>https://orcid.org/0000-0002-2734-516X</orcidid><orcidid>https://orcid.org/0000-0003-2170-7462</orcidid><orcidid>https://orcid.org/0000-0002-8961-859X</orcidid></search><sort><creationdate>201912</creationdate><title>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</title><author>He, Zhengxiang ; Chen, Lili ; Chen, Grace ; Smaldini, Paola ; Bongers, Gerold ; Catalan-Dibene, Jovani ; Furtado, Glaucia C. ; Lira, Sergio A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-b4fee55d7ae39bde02f24e9a44863fca80a2dbbcbb3778feb30ee372dd06cb523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis - immunology</topic><topic>Barrier Breakdown</topic><topic>Cecum - cytology</topic><topic>Cecum - immunology</topic><topic>Cecum - pathology</topic><topic>Colonic Polyps - immunology</topic><topic>Cytokine</topic><topic>Diphtheria Toxin - administration &amp; dosage</topic><topic>Diphtheria Toxin - immunology</topic><topic>Disease Models, Animal</topic><topic>Epithelial Cells - immunology</topic><topic>Epithelial Cells - pathology</topic><topic>ErbB Receptors - antagonists &amp; inhibitors</topic><topic>ErbB Receptors - metabolism</topic><topic>Fibroblasts - immunology</topic><topic>Fibroblasts - metabolism</topic><topic>Gefitinib - pharmacology</topic><topic>Heparin-binding EGF-like Growth Factor - genetics</topic><topic>Heparin-binding EGF-like Growth Factor - metabolism</topic><topic>Humans</topic><topic>Hydroxamic Acids - pharmacology</topic><topic>Interleukin-1beta - immunology</topic><topic>Interleukin-1beta - metabolism</topic><topic>Intestinal Mucosa - cytology</topic><topic>Intestinal Mucosa - immunology</topic><topic>Intestinal Mucosa - pathology</topic><topic>Matrix Metalloproteinase 3 - immunology</topic><topic>Matrix Metalloproteinase 3 - metabolism</topic><topic>Matrix Metalloproteinase Inhibitors - pharmacology</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Neoplasm</topic><topic>Receptor, Platelet-Derived Growth Factor alpha - metabolism</topic><topic>Stroma</topic><topic>Sulfonamides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Zhengxiang</creatorcontrib><creatorcontrib>Chen, Lili</creatorcontrib><creatorcontrib>Chen, Grace</creatorcontrib><creatorcontrib>Smaldini, Paola</creatorcontrib><creatorcontrib>Bongers, Gerold</creatorcontrib><creatorcontrib>Catalan-Dibene, Jovani</creatorcontrib><creatorcontrib>Furtado, Glaucia C.</creatorcontrib><creatorcontrib>Lira, Sergio A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Zhengxiang</au><au>Chen, Lili</au><au>Chen, Grace</au><au>Smaldini, Paola</au><au>Bongers, Gerold</au><au>Catalan-Dibene, Jovani</au><au>Furtado, Glaucia C.</au><au>Lira, Sergio A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2019-12</date><risdate>2019</risdate><volume>157</volume><issue>6</issue><spage>1572</spage><epage>1583.e8</epage><pages>1572-1583.e8</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor–like growth factor) and a constitutively active G protein–coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps. We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing. Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation. In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp–associated molecules and indicate roles for immune and stromal cells in serrated polyp development. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31470007</pmid><doi>10.1053/j.gastro.2019.08.025</doi><orcidid>https://orcid.org/0000-0002-3187-120X</orcidid><orcidid>https://orcid.org/0000-0002-2734-516X</orcidid><orcidid>https://orcid.org/0000-0003-2170-7462</orcidid><orcidid>https://orcid.org/0000-0002-8961-859X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2019-12, Vol.157 (6), p.1572-1583.e8
issn 0016-5085
1528-0012
language eng
recordid cdi_proquest_miscellaneous_2283106221
source MEDLINE; Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection
subjects Animals
Apoptosis - immunology
Barrier Breakdown
Cecum - cytology
Cecum - immunology
Cecum - pathology
Colonic Polyps - immunology
Cytokine
Diphtheria Toxin - administration & dosage
Diphtheria Toxin - immunology
Disease Models, Animal
Epithelial Cells - immunology
Epithelial Cells - pathology
ErbB Receptors - antagonists & inhibitors
ErbB Receptors - metabolism
Fibroblasts - immunology
Fibroblasts - metabolism
Gefitinib - pharmacology
Heparin-binding EGF-like Growth Factor - genetics
Heparin-binding EGF-like Growth Factor - metabolism
Humans
Hydroxamic Acids - pharmacology
Interleukin-1beta - immunology
Interleukin-1beta - metabolism
Intestinal Mucosa - cytology
Intestinal Mucosa - immunology
Intestinal Mucosa - pathology
Matrix Metalloproteinase 3 - immunology
Matrix Metalloproteinase 3 - metabolism
Matrix Metalloproteinase Inhibitors - pharmacology
Mice
Mice, Transgenic
Neoplasm
Receptor, Platelet-Derived Growth Factor alpha - metabolism
Stroma
Sulfonamides - pharmacology
title Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor–Dependent Serrated Polyps in Mouse Cecum
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T15%3A38%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin%201%20beta%20and%20Matrix%20Metallopeptidase%203%20Contribute%20to%20Development%20of%20Epidermal%20Growth%20Factor%20Receptor%E2%80%93Dependent%20Serrated%20Polyps%20in%20Mouse%20Cecum&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=He,%20Zhengxiang&rft.date=2019-12&rft.volume=157&rft.issue=6&rft.spage=1572&rft.epage=1583.e8&rft.pages=1572-1583.e8&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2019.08.025&rft_dat=%3Cproquest_cross%3E2283106221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2283106221&rft_id=info:pmid/31470007&rft_els_id=S0016508519412456&rfr_iscdi=true